Furthermore, through risk score analysis based on bulk-seq, we observed that the elevated expression of FBXL5, PSMB2, and PSMD12 was inversely correlated with poor prognosis, suggesting their protective role in CRC. The gene discussed is PSMD12; the disease is colorectal carcinoma.